Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit

Kyverna Therapeutics is one step closer to launching the first cell therapy for an autoimmune disease, with new data in hand showing many patients remained off of other therapies a…

STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Read the original at statnews.com →

More in Health & Medicine

More from Thursday 24 September →